Evonik Industries AG (ETR:EVK)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,596	7,796	8,621	8,358	13,267	12,410
Market Cap Growth	-8.14%	-9.57%	3.15%	-37.00%	6.90%	-1.98%
Enterprise Value	7,282	11,339	12,316	12,104	16,011	16,027
Last Close Price	16.30	15.75	16.39	14.89	22.56	20.33
PE Ratio	17.81	35.12	-	15.48	17.78	26.69
Forward PE	10.21	11.81	15.58	12.19	14.53	14.71
PS Ratio	0.52	0.51	0.56	0.45	0.89	1.02
PB Ratio	0.89	0.86	0.96	0.76	1.42	1.53
P/TBV Ratio	2.29	2.25	2.54	1.58	4.07	5.81
P/FCF Ratio	14.81	8.93	10.76	10.65	14.28	16.10
P/OCF Ratio	5.73	4.55	5.41	5.07	7.31	7.19
PEG Ratio	-	0.37	-	-	1.03	-
EV/Sales Ratio	0.50	0.75	0.81	0.66	1.07	1.31
EV/EBITDA Ratio	3.53	6.69	6.86	5.19	7.43	9.37
EV/EBIT Ratio	6.97	13.60	20.29	8.83	12.56	18.66
EV/FCF Ratio	14.19	12.99	15.38	15.42	17.24	20.79
Debt / Equity Ratio	-	0.42	0.48	0.38	0.40	0.49
Debt / EBITDA Ratio	-	2.02	2.16	1.70	1.64	2.12
Debt / FCF Ratio	-	4.33	5.32	5.38	4.05	5.10
Asset Turnover	0.75	0.76	0.73	0.84	0.69	0.57
Inventory Turnover	4.16	4.49	4.60	5.28	5.00	4.80
Quick Ratio	0.54	0.65	0.77	0.96	0.83	0.93
Current Ratio	1.45	1.36	1.46	1.83	1.53	1.70
Return on Equity (ROE)	5.00%	2.65%	-4.51%	5.42%	8.80%	5.86%
Return on Assets (ROA)	3.27%	2.63%	1.82%	3.89%	3.69%	2.50%
Return on Capital (ROIC)	5.86%	3.99%	2.66%	6.03%	6.33%	4.19%
Return on Capital Employed (ROCE)	6.80%	5.30%	3.80%	7.50%	7.00%	4.80%
Earnings Yield	5.58%	2.85%	-5.39%	6.46%	5.62%	3.75%
FCF Yield	6.75%	11.20%	9.29%	9.39%	7.00%	6.21%
Dividend Yield	6.70%	7.43%	7.14%	7.86%	5.19%	5.66%
Payout Ratio	128.54%	245.50%	-	100.93%	71.85%	115.27%
Total Shareholder Return	8.26%	7.43%	7.14%	7.86%	5.19%	5.66%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.